نتائج البحث - David I. Quinn

تنقيح النتائج
  1. 1
    Targeted α-Particle Therapy of Bone Metastases in Prostate Cancer

    Targeted α-Particle Therapy of Bone Metastases in Prostate Cancer حسب Hossein Jadvar, David I. Quinn

    منشور في 2013
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Differentiating mTOR inhibitors in renal cell carcinoma

    Differentiating mTOR inhibitors in renal cell carcinoma حسب Sumanta K. Pal, David I. Quinn

    منشور في 2013
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions

    Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions حسب Michael B. Atkins, Joseph I. Clark, David I. Quinn

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Comparative effectiveness of screening strategies for colorectal cancer

    Comparative effectiveness of screening strategies for colorectal cancer حسب Afsaneh Barzi, Heinz‐Josef Lenz, David I. Quinn, Sarmad Sadeghi

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms

    Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms حسب David I. Quinn, Neal D. Shore, Shin Egawa, Winald R. Gerritsen, Karim Fizazi

    منشور في 2015
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    The evolution of chemotherapy for the treatment of prostate cancer

    The evolution of chemotherapy for the treatment of prostate cancer حسب David I. Quinn, Howard M. Sandler, Lisa G. Horvath, Amir Goldkorn, James A. Eastham

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Randomized Controlled Trial of Collaborative Care Management of Depression Among Low-Income Patients With Cancer

    Randomized Controlled Trial of Collaborative Care Management of Depression Among Low-Income Patients With Cancer حسب Kathleen Ell, Bin Xie, Brenda Quon, David I. Quinn, Megan Dwight‐Johnson, Pey-Jiuan Lee

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Aggressive cutaneous malignancies following cardiothoracic transplantation

    Aggressive cutaneous malignancies following cardiothoracic transplantation حسب Michael Veness, David I. Quinn, Colin S. Ong, Anne Keogh, Peter S Macdonald, Stephen G. Cooper, Graeme Morgan

    منشور في 1999
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Baseline <sup>18</sup>F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer

    Baseline <sup>18</sup>F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer حسب Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan Groshen, Jacek Pinski, David I. Quinn

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases

    Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over... حسب Anirban P. Mitra, Jie Cai, Gus Miranda, Sumeet Bhanvadia, David I. Quinn, Anne Schuckman, Hooman Djaladat, Siamak Daneshmand

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    A Phase I/<scp>IB</scp>, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial Carcinoma

    A Phase I/<scp>IB</scp>, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced... حسب Roberto Pili, David I. Quinn, Nabil Adra, Theodore F. Logan, Sean Colligan, Heather N. Burney, Noah M. Hahn

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Fasting and cancer treatment in humans: A case series report

    Fasting and cancer treatment in humans: A case series report حسب Fernando M. Safdie, Tanya B. Dorff, David I. Quinn, Luigi Fontana, Min Wei, Changhan Lee, Pinchas Cohen, Valter D. Longo

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer

    Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer حسب Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan Groshen, Mitchell E. Gross, Jacek Pinski, David I. Quinn

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Radium-223 mechanism of action: implications for use in treatment combinations

    Radium-223 mechanism of action: implications for use in treatment combinations حسب Michael J. Morris, Eva Corey, Theresa A. Guise, James L. Gulley, William Kevin Kelly, David I. Quinn, Arne Scholz, George Sgouros

    منشور في 2019
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer

    Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer حسب Mitchell E. Gross, David B. Agus, Tanya B. Dorff, Jacek Pinski, David I. Quinn, Olga Castellanos, Patrick Gilmore, Jean C. Shih

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial

    Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial حسب Przemyslaw Twardowski, Walter M. Stadler, Paul Frankel, Primo N. Lara, Christopher Ruel, Gurkamal Chatta, Elisabeth I. Heath, David I. Quinn, David R. Gandara

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Robotic salvage retroperitoneal and pelvic lymph node dissection for ‘node‐only’ recurrent prostate cancer: technique and initial series

    Robotic salvage retroperitoneal and pelvic lymph node dissection for ‘node‐only’ recurrent prostate cancer: technique and initial series حسب Andre Luis Abreu, Carlos Fay, Daniel Park, David I. Quinn, Tanya B. Dorff, John Carpten, Peter Kühn, Parkash S. Gill, Fábio Almeida, Inderbir S. Gill

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study

    A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study حسب Primo N. Lara, Jeff Longmate, Christopher P. Evans, David I. Quinn, Przemyslaw Twardowski, Gurkamal Chatta, Edwin M. Posadas, Walter M. Stadler, David R. Gandara

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Human immunodeficiency virus–related primary central nervous system lymphoma

    Human immunodeficiency virus–related primary central nervous system lymphoma حسب M. Newell, Jennifer Hoy, Stephen G. Cooper, Bernadette DeGraaff, Andrew E. Grulich, Melissa B. Bryant, Jeremy Millar, Bruce J. Brew, David I. Quinn

    منشور في 2004
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis

    Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis حسب Raj Satkunasivam, Andre E. Kim, Mihir Desai, Mike Nguyen, David I. Quinn, Leslie K. Ballas, Juan Pablo Lewinger, Mariana C. Stern, Ann S. Hamilton, Monish Aron, Inderbir S. Gill

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: